Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks
2019-06-08 23:45
ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic
2019-06-08 07:01
Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards
2019-06-07 23:23
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
2019-06-06 18:00
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
2019-06-06 18:00
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC
2019-06-05 19:56
Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO
2019-06-05 08:00
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer
2019-06-04 21:00
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
2019-06-04 20:17
Medtec China will expand to 2 Halls in 2020 for the first time
2019-06-04 19:11
New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy(1)
2019-06-04 14:00
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma
2019-06-04 08:00
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma
2019-06-04 08:00
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
2019-06-04 08:00
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO
2019-06-04 07:00
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa
2019-06-04 06:39
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations
2019-06-04 02:16
Frost & Sullivan Publishes Q1 Update on Kadimastem
2019-06-03 21:24
Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology
2019-06-03 20:30
International Medical Innovation and Cooperation Forum held in Fangchenggang City
2019-06-03 19:43
1
639
640
641
642
643
963